Drug Eluting Stent News and Research

RSS
A drug-eluting stent (DES) is a coronary stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombus), could otherwise block the stented artery, a process called restenosis.
Ceram-lead project to develop new biomaterials and new arterial stents awarded Euro 5.874M by the European Union

Ceram-lead project to develop new biomaterials and new arterial stents awarded Euro 5.874M by the European Union

First commercial implant of Elixir's DESolve Novolimus Eluting Coronary Scaffold performed in Germany

First commercial implant of Elixir's DESolve Novolimus Eluting Coronary Scaffold performed in Germany

Equations help explain key parameters of stents that combat artherosclerosis

Equations help explain key parameters of stents that combat artherosclerosis

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

The Medicines Company, Boston Scientific announce co-promotion agreement for Promus PREMIER stent system

Svelte completes enrollment in drug-eluting coronary stent Integrated Delivery System study

Svelte completes enrollment in drug-eluting coronary stent Integrated Delivery System study

Six-month surgery delay ‘acceptable’ after DES implantation

Six-month surgery delay ‘acceptable’ after DES implantation

Auckland physician performs first patient implant of Boston Scientific Innova DES System

Auckland physician performs first patient implant of Boston Scientific Innova DES System

Test evaluates benefits of fully dissolvable and temporary drug eluting stent to open heart artery blockages

Test evaluates benefits of fully dissolvable and temporary drug eluting stent to open heart artery blockages

Abbott starts ABSORB Japan trial to evaluate Absorb BVS in patients with CAD

Abbott starts ABSORB Japan trial to evaluate Absorb BVS in patients with CAD

OrbusNeich introduces COMBO Dual Therapy Stent

OrbusNeich introduces COMBO Dual Therapy Stent

Study analyzes potential usefulness of new treatment to reopen clogged arteries

Study analyzes potential usefulness of new treatment to reopen clogged arteries

Elixir's DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System receives CE Mark approval

Elixir's DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System receives CE Mark approval

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Drug-eluting stents can keep clogged leg arteries open and prevent leg amputation

Drug-eluting stents can keep clogged leg arteries open and prevent leg amputation

Riverside Methodist Hospital treats first PAD patient with Cook Medical's Zilver PTX device

Riverside Methodist Hospital treats first PAD patient with Cook Medical's Zilver PTX device

Enrollment complete in Tryton's Pivotal IDE Side Branch Stent trial to treat bifurcation lesions

Enrollment complete in Tryton's Pivotal IDE Side Branch Stent trial to treat bifurcation lesions

FDA approves Cook's Zilver PTX drug-eluting peripheral stent

FDA approves Cook's Zilver PTX drug-eluting peripheral stent

Cook receives FDA approval for Zilver PTX Drug-Eluting Peripheral Stent to treat PAD

Cook receives FDA approval for Zilver PTX Drug-Eluting Peripheral Stent to treat PAD

Mesh-covered stent improves restoration of blood flow after PCI in heart attack patients

Mesh-covered stent improves restoration of blood flow after PCI in heart attack patients

PROTECT: Still no clear winner in the battle of the stent generations

PROTECT: Still no clear winner in the battle of the stent generations